CORESTEMCHEMON Inc.
Develops stem cell therapies and provides non-clinical CRO preclinical services.
166480 | KO
Overview
Corporate Details
- ISIN(s):
- KR7166480004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로255번길 24 (삼평동), 성남시
Description
CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-18 00:00 |
사업보고서 (2020.12)
|
Korean | 462.2 KB | ||
| 2021-03-10 00:00 |
주주총회소집공고
|
Korean | 830.1 KB | ||
| 2021-03-10 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2021-02-25 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2021-02-25 00:00 |
파생상품거래손실발생
|
Korean | 6.6 KB | ||
| 2021-02-25 00:00 |
주주총회소집결의
|
Korean | 11.0 KB | ||
| 2021-02-25 00:00 |
[기재정정]주주총회소집결의
|
Korean | 14.2 KB | ||
| 2021-01-26 00:00 |
기타시장안내(연구개발 우수기업 매출액 특례적용 관련)
|
Korean | 2.7 KB | ||
| 2020-11-30 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 58.4 KB | ||
| 2020-11-26 00:00 |
기타경영사항(자율공시)(미국 MGH가 미국 FDA에 신청한 뉴로나타-알주의 응급 임상 요청에 대한 승인)
|
Korean | 4.5 KB | ||
| 2020-11-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-11-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-11-18 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 868.8 KB | ||
| 2020-11-11 00:00 |
투자판단관련주요경영사항(뉴로나타-알주 임상 3상 시험 관련 R-MAT 신청에 관한 미지정 결과 회신(미국FDA))
|
Korean | 7.9 KB |
Automate Your Workflow. Get a real-time feed of all CORESTEMCHEMON Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CORESTEMCHEMON Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CORESTEMCHEMON Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
